Literature DB >> 31300488

Plasma exchange in neurological disease.

Chinar Osman1, Rachel Jennings2, Khaled El-Ghariani3, Ashwin Pinto2.   

Abstract

Plasma exchange is a highly efficient technique to remove circulating autoantibodies and other humoral factors rapidly from the vascular compartment. It was the first effective acute treatment for peripheral disorders such as Guillain-Barré syndrome and myasthenia gravis before intravenous immunoglobulin became available. The recent recognition of rapidly progressive severe antibody-mediated central nervous system disorders, such as neuromyelitis optica spectrum disorders and anti-N-methyl-D-aspartate-receptor encephalitis, has renewed interest in using plasma exchange for their acute treatment also. In this review we explain the principles and technical aspects of plasma exchange, review its current indications, and discuss the implications for its provision in the UK. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  clinical neurology; evidence-based neurology; neuroimmunology

Mesh:

Substances:

Year:  2019        PMID: 31300488     DOI: 10.1136/practneurol-2019-002336

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  7 in total

1.  Clinical efficacy of high-dose intravenous gammaglobulin in acute Guillain-Barre syndrome and effect on serum concentration of inflammatory factors.

Authors:  Lifeng Lv; Haijuan Xu; Haining Zhang; Qinde Qi
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

2.  Effects of Plasma Exchange Combined with Immunoglobulin Therapy on Consciousness, Immune Function, and Prognosis in Patients with Myasthenia Gravis Crisis: A Prospective Randomized Test.

Authors:  Xu Peng; Xiao-Bi Xie; Hong Tan; Dan Zhang; Bo-Tao Jiang; Jie Liu; Shuang Li; Ya-Rui Chen; Tao-Yang Xie
Journal:  Comput Math Methods Med       Date:  2022-06-30       Impact factor: 2.809

3.  Th1 - CD11c+ B Cell Axis Associated with Response to Plasmapheresis in Multiple Sclerosis.

Authors:  Kimitoshi Kimura; Youwei Lin; Hiromi Yamaguchi; Wakiro Sato; Daiki Takewaki; Misako Minote; Yoshimitsu Doi; Tomoko Okamoto; Ryosuke Takahashi; Takayuki Kondo; Takashi Yamamura
Journal:  Ann Neurol       Date:  2021-10       Impact factor: 11.274

Review 4.  Human hepatitis viruses-associated cutaneous and systemic vasculitis.

Authors:  Chrong-Reen Wang; Hung-Wen Tsai
Journal:  World J Gastroenterol       Date:  2021-01-07       Impact factor: 5.742

5.  Clinical efficacy of plasma exchange in patients with autoimmune encephalitis.

Authors:  Yan Zhang; Hui-Jin Huang; Wei-Bi Chen; Gang Liu; Fang Liu; Ying-Ying Su
Journal:  Ann Clin Transl Neurol       Date:  2021-02-20       Impact factor: 4.511

Review 6.  Consensus recommendation on the use of therapeutic plasma exchange for adult neurological diseases in Southeast Asia from the Southeast Asia therapeutic plasma exchange consortium.

Authors:  Fu Liong Hiew; Win Min Thit; Mathew Alexander; Umapathi Thirugnanam; Sasitorn Siritho; Kevin Tan; Seinn Mya Mya Aye; Ohnmar Ohnmar; Riwanti Estiasari; Norazieda Yassin; Paul Matthew Pasco; Say Saysavath Keosodsay; Hoang Tien Trong Nghia; Md Badrul Islam; Sing Keat Wong; Shirley Lee; Anupam Chhabra; Shanthi Viswanathan
Journal:  J Cent Nerv Syst Dis       Date:  2021-11-25

7.  Lymphoplasma Exchange Improves Myasthenia Gravis Exacerbations: A Retrospective Study in a Chinese Center.

Authors:  Song Ouyang; Weifan Yin; Qiuming Zeng; Bijuan Li; Jian Zhang; Weiwei Duan; Yi Li; Yong Liang; Jiaqi Wang; Hong Tan; Huan Yang
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.